Pfizer CEO Sells Stock Same Day Positive Results of COVID-19 Vaccine Announced

Pfizer CEO Sells Stock Same Day Positive Results of COVID-19 Vaccine Announced

Story Highlights On Nov. 9, 2020, Pfizer released preliminary Phase 3 clinical trial data indicating that its experimental mRNA COVID-19 vaccine is 90 percent effective, triggering a big surge in stock price. Pfizer CEO Albert Bourla immediately sold 60 percent of his company stock, realizing a gain of $5.6 million in what the company called […]

Only Half of Americans Polled Say They Would Get COVID-19 Vaccine

Only Half of Americans Polled Say They Would Get COVID-19 Vaccine

In a poll conducted for CNN during Oct. 1-4, 2020, the Pennsylvania-based market research firm SSRS found that 51 percent of the 1,205 Americans surveyed said they would try to get a COVID-19 vaccine if it were widely available at a low cost, 45 percent said they would not and four percent had no opinion. Sixty […]

Polls Find Many Americans Do Not Want COVID-19 Vaccine as Soon as It’s Licensed

Polls Find Many Americans Do Not Want COVID-19 Vaccine as Soon as It’s Licensed

Story Highlights More adults in the U.S. are expressing doubts about the safety of a newly licensed COVID-19 vaccine that might become available this year. The number of poll respondents planning on getting a new coronavirus vaccine as soon as it is FDA approved has fallen from a reported high of 50 to 60 percent […]

Makers of Experimental COVID-19 Vaccines Lobby EU for Liability Protection

Makers of Experimental COVID-19 Vaccines Lobby EU for Liability Protection

Vaccines Europe, a pharmaceutical industry lobbying group, has issued a memo to its member companies saying it would seek liability protection from the European Union (EU) for corporations manufacturing COVID-19 vaccines. The memo, obtained by the Financial Times, expressed concern about the “inevitable risks” of rushing the development and global marketing of COVID-19 vaccines.1 2 3 […]

Novartis Pays $678 Million for Kickbacks to Doctors

Novartis Pays $678 Million for Kickbacks to Doctors

Novartis Pharmaceuticals Corp. of East Hanover, New Jersey has agreed to pay $678 million to settle a civil fraud lawsuit in which the U.S. government accused the company of illegally providing doctors with cash payments and other gifts for prescribing their cardiovascular and diabetes drugs between 2002 and 2011.1 Assistant Attorney General Jody Hunt of […]

Genetically Engineered Cow Plasma Therapy for COVID-19 Will Be Tested on Humans

Genetically Engineered Cow Plasma Therapy for COVID-19 Will Be Tested on Humans

Story Highlights Human trials for a new COVID-19 immunotherapy candidate (SAB-185) that is derived from genetically engineered cow plasma will begin in July 2020. The cows have been genetically engineered to produce human antibodies to fight off COVID-19. Plasma from the cows is expected to assist COVID-19 patients overcome the infection. SAb Biotherapeutics (SAB), a […]

Rapid Tests for Coronavirus Raise Concerns Over Accuracy

Rapid Tests for Coronavirus Raise Concerns Over Accuracy

On Mar. 27, 2020, the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) to pharmaceutical and medical devices company Abbott Laboratories, Inc. of Abbott Park, Illinois for a rapid diagnostic test for the SARS-CoV-2 virus known as ID NOW.1 2 3 “We know how important it is to get point-of-care tests out […]

Anti-Depressants in Short Supply During COVID-19 Lockdowns

Anti-Depressants in Short Supply During COVID-19 Lockdowns

Drug shortages listed by the U.S Food and Drug Administration (FDA) are exposing some of the ramifications of responses to the COVID-19 pandemic, including state lockdowns and social distancing regulations.1 Zoloft (sertraline hydrochloride), an anti-depressant manufactured by Pfizer and its generic counterparts produced by other drug makers, have been added to the FDA’s list of […]

Poll Finds Only Half of Americans Plan to Get COVID-19 Vaccine

Poll Finds Only Half of Americans Plan to Get COVID-19 Vaccine

A recent poll conducted by the Associated Press’s NORC Center for Public Affairs Research found that 20 percent of Americans anticipate that a COVID-19 vaccine will be available to the public before the end of 2020, while 61 percent expect it during 2021. Only 17 percent believe it will take longer than that to develop.1 […]

COVID-19 Related Drug Shortage in U.S. Because China Supplies Most Ingredients

COVID-19 Related Drug Shortage in U.S. Because China Supplies Most Ingredients

Story Highlights The FDA has reported its first drug shortage as a result of the COVID-19 outbreak in China. Many drug ingredients and finished drug products used in the U.S are sourced and manufactured in China. The possibility of potential drug shortages highlights the issue of how the U.S. is heavily reliant on China for […]

1 2 3 5